Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02773121 · ClinicalTrials.gov registry record · NA
Physical Activity and Cognition Study
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02773121: Completed NA study, sponsored by Boston University.
NCT02773121 is a NA study that has completed, run by Boston University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02773121, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The goal of this research study is to examine whether an intervention to increase physical activity using a body-worn sensor affects cognitive (thinking) processes.
Primary Outcome
Change in cognitive task performance post-intervention compared to baseline
Interventions
- BEHAVIORAL Physical Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2020-01-17 |
| Phase | NA |
What the finished NCT02773121 record still lists
NCT02773121 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Physical Activity is the first listed.
NCT02773121 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02773121 about?
NCT02773121 is a clinical study titled "Physical Activity and Cognition Study". The goal of this research study is to examine whether an intervention to increase physical activity using a body-worn sensor affects cognitive (thinking) processes.
What is the current status of trial NCT02773121?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2017-03-01. Estimated completion is 2020-01-17.
What interventions are being tested in trial NCT02773121?
The interventions under investigation include: Physical Activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT02773121?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02773121's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI